IGF2BP3 and neoplasm: In addition, IGF2BP3 is also associated with chemo-resistance and poor disease outcomes not only in OCCCs but also in other types of ovarian carcinoma, demonstrating the potential usefulness of IGF2BP3 as a novel biomarker for various tumor types, due largely to its involvement in cell invasion and metastasis.